Stock of the Day

April 12, 2021

Corteva (CTVA)

$12.85
-$0.56 (-4.1%)
Market Cap: $8.94B

About Corteva

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

Corteva Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

  • The stock is currently trading at $13.40, which is significantly below the average analyst price target of $60.59, suggesting a substantial potential for upside if the market re-evaluates the company's value relative to its peers.
  • Corteva, Inc. offers a high dividend yield of 5.39%, providing a steady income stream for investors, supported by a sustainable payout ratio of 47.68% which indicates the company retains enough earnings to fund operations while rewarding shareholders.
  • Recent earnings reports show the company beating consensus estimates, such as the July 30th report where earnings per share of $2.30 exceeded the expected $2.24, demonstrating operational resilience and effective cost management despite revenue headwinds.
  • The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.07 and a current ratio of 1.52, indicating high financial stability and the ability to meet short-term obligations without significant leverage risk.
  • With a beta of 0.57, Corteva, Inc. exhibits lower volatility than the broader market, making it a potentially defensive holding that may offer more stable returns during periods of market uncertainty.

Corteva Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

  • The stock has experienced a dramatic decline, trading at $13.40 which is near its 52-week low of $11.74 and far below its 52-week high of $90.97, indicating severe market devaluation and potential ongoing structural issues.
  • Recent analyst actions include a downgrade to "Strong Sell" by Zacks Research and a price target cut to $15.00 by UBS, reflecting a bearish outlook from key financial institutions regarding the company's near-term prospects.
  • Revenue has shown signs of weakness, with the most recent quarter reporting a 1.2% year-over-year decline to $6.38 billion, missing the consensus estimate of $6.60 billion, which suggests demand challenges in the agricultural sector.
  • Short interest has been increasing, with shares shorted rising to 21.6 million in the latest reporting period, and days to cover increasing to 4.75, indicating growing bearish sentiment among traders who expect further price declines.
  • Several members of Congress, including Rep. Gilbert Cisneros and Rep. Ro Khanna, have recently sold their positions in Corteva, Inc., which may signal a lack of confidence among politically connected investors in the company's future performance.

Recent News